Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Your writing skills can generate income in various ways. Discover opportunities to turn your talent into cash.
17,868 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A 25-year-old saving $300 monthly could accumulate more retirement wealth by 65 than a 40-year-old saving $800 monthl...
In 2026, equal-weight XSD and cap-weight SMH offer contrasting bets on AI-driven chipmakers. This article analyzes ho...
Geopolitical frictions in the Strait of Hormuz push oil prices higher, reshaping risk and opportunity for energy inve...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
Two power players, two paths: Constellation Energy and Vistra offer differing mixes of stability and upside. This gui...
Novo Nordisk stock investors faced volatility after softer results and cautious guidance, but momentum around Wegovy ...
Investors are watching Sinclair (SBGI) 2025 earnings closely as local ad markets and political cycles shape cash flow...
March trading action kept pushing higher as Plug Power surged again, helping to lead a broader market rally. This art...
Wall Street and crypto traders watch a quiet moment for Bitcoin as geopolitical tensions cool and ETF inflows grow. T...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...